# Open-Label Study of H5 Vaccine in Participants of Protocol 04-077

> **NCT00402649** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 35 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)

## Key facts

- **NCT ID:** NCT00402649
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2011-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00402649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00402649, "Open-Label Study of H5 Vaccine in Participants of Protocol 04-077". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00402649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*